|
Antibody
Investigational
Unknown
Unknown
Ascites; Carcinoma, Pancreatic Ductal; Digestive System Neoplasms; Endometrial Neoplasms; Leukemia; Lymphoma, T-Cell; Lymphoma, T-Cell, Peripheral; Adenocarcinoma of Lung; Astrocytoma; Biliary Tract Neoplasms; Carcinoma; Carcinoma, Renal Cell; Carcinoma, Squamous Cell; Colonic Neoplasms; Colorectal Neoplasms; Glioblastoma; Granuloma, Lethal Midline; Head and Neck Neoplasms; Kidney Neoplasms; Liver Neoplasms; Lung Neoplasms; Lymphoma; Lymphoma, Non-Hodgkin; Melanoma; Nasopharyngeal Neoplasms; Oligodendroglioma; Ovarian Neoplasms; Pancreatic Neoplasms; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Thyroid Neoplasms; Triple Negative Breast Neoplasms; Uterine Cervical Neoplasms; Breast Neoplasms; Carcinoma, Hepatocellular; Cholangiocarcinoma; Hodgkin Disease; Lymphoma, Large B-Cell, Diffuse; Nasopharyngeal Carcinoma; Rectal Neoplasms; Small Cell Lung Carcinoma; Squamous Cell Carcinoma of Head and Neck; Urinary Bladder Neoplasms; Adenocarcinoma; Carcinoma, Non-Small-Cell Lung; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Neoplasms; Stomach Neoplasms
Programmed cell death protein 1 inhibitor
|